Company: RNAC
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001453687-25-000085
Chunk: 81

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 2
Chunk 81
---
4.8-K001-377983.13/28/20244.2Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock8-K001-377983.17/2/202410.1†Third Amendment to Lease Agreement by and between 7495 RP, LLC and Cartesian Therapeutics, Inc. dated March 12, 2025---Filed herewith10.2†#Separation Agreement and Release by and between Metin Kurtoglu and Cartesian Therapeutics, Inc. dated April 29, 2025---Filed herewith31.1Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002---Filed herewith31.2Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002---Filed herewith32.1Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002---Furnished herewith101.INSInline XBRL Instance Document (the Instance Document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document)---Filed herewith101.SCHInline XBRL Taxonomy Extension Schema Document---Filed herewith101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document---Filed herewith

40

Table of Contents

101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document---Filed herewith101.LABInline XBRL Taxonomy Extension Label Linkbase Document---Filed herewith101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document---Filed herewith104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)---Filed herewith

* Certain annexes, schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.    

† Certain confidential information contained in this exhibit, marked by